# Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD

> **NCT02357576** · PHASE3 · COMPLETED · sponsor: **University of Michigan** · enrollment: 22 (actual)

## Conditions studied

- Cholestasis

## Interventions

- **DRUG:** Intralipid 20% I.V. Fat Emulsion

## Key facts

- **NCT ID:** NCT02357576
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-21
- **Primary completion:** 2017-10-12
- **Final completion:** 2019-11-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02357576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02357576, "Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02357576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*